País: Brasil
Língua: português
Origem: ANVISA (Agência Nacional de Vigilância Sanitária)
CAPTOPRIL
BRASTERAPICA INDUSTRIA FARMACEUTICA EIRELI
ANTI-HIPERTENSIVOS SIMPLES
CAPTOPRIL
ANTI-HIPERTENSIVOS SIMPLES
25 MG COM CT BL AL PLAS TRANS X 30 - 1003800990013 - - Venda sob Prescrição Médica - COMPRIMIDO SIMPLES; 25 MG COM CT BL AL PLAS TRANS X 500 - 1003800990021 - - Venda sob Prescrição Médica - COMPRIMIDO SIMPLES
Cancelado/Caduco
2015-09-28
1234562789 3 45293323 59 35 3 1234562789 3 45293323 59 35 3 !"# 1234562789 3 45293323 59 35 3 01233 4 6789 8 000000 00 ! " #8#$ %&'(#)&*#+7 7),#6 -9,-$ ./6 #8#$ %0 0 0 1 "7$76 #8#$ $,01233 4 6 -92#'(#)$,6789 8 0 *368,-9,%46, 5 %,#6 6%97-76 769 %,# -$797$766 %67#, %,%7$676$73$ $,% 86 , 96$ ,%9,96 0 0 !00: ;<000=0> 01233 4 2-$67$ 8779797876,-9,%6 #4 &?8,9,-%@ A &-%5B6C-6767$87676 -),%9D7E5%7$ 6 # 59 %#,$67#,-9 %$5296 %,$)996 %FA &-B79 $ # 69$ A &-,B 8797$7+2967E$ ,-G7,-7 675%7$78$7+,9,%F0 H<00> 01233 4 $#-578,%%@ 79,7 0I#7 #,-9,6 6,#,$5GJ,%#93#7%$78,%%@ 79,7 K/7L/ #-59 %787%7-),%9@ $7$ %,0M$#-5G@ $78,%%@ 79,7 8 $,%,8 ),%%D7A7%%#6877%, +9,#, ?,%,%5 97$ %68 $,#%,-,6,%%97%D97%%,#7-7%$,9797#,-9 0 N<0100> 1O32PQORQSPTUVW X 6C-@ $,D,59Y701233 4 %,Z99,D,,7GJ,%7 2)67%7-9,,%6 # 5% $,%9,#,$67#,-9 5 [57 [5, 59 #,$67#,-9 [5,7Z7$7#,%#7#7-,7[5, 6789 8 0 W3V\VRQSP\VO31O]1RV^VWV2_3Q`QaPR1b12\_`cV2VWd2e^QRPWWV\12QVO3PT]1\fRQSP< Og12\VQ\VRQP3P\VO3VWV_\fRQS1V\SPW1RVW_WbVQ3PRVd2P^QRVa< h<0i000> 0R^V23jOSQPW X 6C$,D,, 797#,$797#,-9,7 %,5#2$6 [57%[5,%-7% 5%-9 #7%[5,8 %%7#-$67 8,%,-G7$,7-) ,$,#766 # 8,3,#8 4-6?7G $7B76,689 8,+7%6 9+ %6 8-)576 7-),, ,39,#$7$,%67%%#6 # $B65 $7$,877,-) 5,%876 5 5[5$@ 0I,%9,%67% %6D 6C$,D,-9, #8, 5% $,%9,#,$67#,-9 0 2VSP_TUVW X 6C$,D,, 797#,$797#,-9,7 %,5#2$6 [57 [5,%-9 #7$,-B,6G@ E80,306$$,)7)7-976 B,+,F6[5,-@ ,%9,Z7,%8 -$,-$ 7 9797#,-9 Leia o documento completo
1234562789 3 45293323 59 35 3 1234562789 3 45293323 59 35 3 !"# 1234562789 3 45293323 59 35 3 01233 4 6789 8 000000 00 ! " #8#$ %&'(#)&*#+7 7),#6 -9,-$ ./ 0(//6 #8#$ %1 0 0 2 "7$76 #8#$ $,01233 4 6 -93#'(#)$,6789 8 1 *468,-9,%56, 0 %,#6 6%97-76 769 %,# -$797$766 %67#, %,%7$676$74$ $,% 86 , 96$ ,%9,96 1 0 !:0000;< =>0 ! ?@AB23BCDE1<6789 8 3-$67$ 877 9797#,-9 $7F8,9,-%G 68,$0H78,%%G 79,7 -,%%,% 67% %1 CDIJ@K@LCK@MM2NOMKM<6789 8 3-$67$ - 9797#,-9 $7-%0P6Q-6767$87676 -),%9R7,# 7%% 67SG 6 #$0396 %,$)996 %1T,P,9 +,-3P6 $,6789 8 -7-%0P6Q-6767$8767-G ,U0,78,%,-S7$,$)996 %1 CJM231N1@1KV2N@1< 6789 8 3-$67$ 6 # 9,78787%&-P79 $ # 69$ ,#876,-9,% 6-67#,-9,,%99R,%6 #$%P0-SG R,-960 7,%U0,$77%%-9 #9967 0%-9 #9967877#, F77 % +,R$768 9, 7 -86 $7-%0P6Q-6767$8767%-9 #99676,$0H-9,-7SW,%8-%0P6Q-67 67$8767,$#-07-6$Q-67$,-P79 $ # 69$ ,6,-9,,7%6 -$097%$,,R7%60 7H7SG 6 -77-71 BJ21AM3@M@MXY3@KM< 6789 8 3-$67$ 877 9797#,-9 $,-,P 8797$7+3967Z8 9,-[7\(// #)]$7^,#876,-9,%6 #$7+,9,%#,90%-%0- $,8,-$,-9,%1_,%9,%876,-9,%6 6789 8 8,R-,7 8 ),%%G $7$ ,-S7,-7 ,,$0H%,U0, 7%6 8-67%7%% 67$7%Z$9%,697-%8 7-9,,-7 ,#9,^1 `>0a0 T9797#,-9 6 #6789 8 ,%0 9 0,##, F7$7% +,R$77 -) 87H ,$ %,%0 97$ %6 8-6 %,# 6 #877SG 7 8 76,+ - ,%90$ bcd*&eb0RR7 7-$d,-960 7*- 7),#,-9f66 #'1'.g876,-9,% 6 #-P79 $ # 69$ 1 T,%90$ #0 96Q-96 67-$ #H7$ 6$08 &6,) 66 -9 7$ 88 76,+ ,-R R,0876,-9,%Z6 #$7$, ,-9,'g&hi7- %^U0,$,# -%97R7#$%P0-SG R,-960 7,%U0,$7ZP7SG $,, Leia o documento completo